Code | 3514B | ||||||||||
MA number | 69/0105/15-S | ||||||||||
Product Form: | pas ocp 20x3 mg (blis.PVC/PE/PVDC/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | BAUSCH HEALTH IRELAND LIMITED, Ireland | ||||||||||
Therapeutic Class: | 69 - OTORHINOLARYNGOLOGICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | blister PVC/PE/PVDC/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product not subject to medical prescription. |
Legal basis: | Article 10(3) hybrid application |
MA issued: | 07.04.2015 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
SPC: | SPC_Garganta 3 mg pastilky_08_2022.pdf |
PIL: | PIL_Garganta 3 mg pastilky_05/2023.pdf |
Safety feature | No |
Data update: | 04.03.2020 |